Rockwell Medical, Inc

3:45 PM - 4:00 PM, Monday, June 3, 2019 ・ Theater 1
Rockwell Medical, Inc. (“Rockwell Medical”) is a specialty pharmaceutical company targeting anemia management in end-stage renal disease (ESRD), chronic kidney disease (CKD) and other areas including but not limited to oncology and Total Parental Nutrition. Triferic® is the ONLY FDA-approved product indicated for iron replacement and maintenance of hemoglobin in hemodialysis patients. In addition, Rockwell is an established manufacturer, supplier and leader in delivering high-quality hemodialysis concentrates/dialysates (used to maintain human life by removing toxins and replacing critical nutrients in the dialysis patient's bloodstream) to dialysis providers and distributors in the U.S. and abroad.
Ticker:
RMTI
Exchange:
NASDAQ
Company Type:
Company Website:
Company HQ State:
Michigan
Company HQ Country:
United States
Year Founded:
Not Provided.
Main Therapeutic Focus:
Lead Product in Development:
Triferic (ferric pyrophosphate citrate)
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
1
Speaker
photo
President & CEO
Rockwell Medical, Inc.